191 related articles for article (PubMed ID: 31225840)
1. Management of Androgen Deprivation Therapy-Associated Hot Flashes in Men With Prostate Cancer.
Qan'ir Y; DeDeaux D; Godley PA; Mayer DK; Song L
Oncol Nurs Forum; 2019 Jul; 46(4):E107-E118. PubMed ID: 31225840
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture for hot flashes in men treated with androgen deprivation therapy.
Hirsch LM; Goldstein LE
Can J Urol; 2015 Aug; 22(4):7938-41. PubMed ID: 26267037
[TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate for the treatment of hot flashes in men undergoing hormone ablation therapy or orchiectomy.
Lajiness MJ
Urol Nurs; 2007 Dec; 27(6):556-7. PubMed ID: 18217540
[No Abstract] [Full Text] [Related]
5. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy.
Hanisch LJ; Gehrman PR
Aging Male; 2011 Dec; 14(4):243-8. PubMed ID: 21627561
[TBL] [Abstract][Full Text] [Related]
6. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.
Higano CS
Urology; 2003 Feb; 61(2 Suppl 1):32-8. PubMed ID: 12667885
[TBL] [Abstract][Full Text] [Related]
7. The management of hot flushes for men treated with androgen deprivation therapy for prostate cancer: a survey of UK practice.
Kinnaird W; Mehta A; Guo C; Payne H; Jenkins V; Catt S
Acupunct Med; 2021 Aug; 39(4):394-395. PubMed ID: 33023298
[No Abstract] [Full Text] [Related]
8. Intravenous nutrient therapy eliminated androgen deprivation therapy-induced hot flashes in two men with prostate cancer.
Massey P
J Soc Integr Oncol; 2006; 4(4):153-6. PubMed ID: 17022923
[TBL] [Abstract][Full Text] [Related]
9. Complications of androgen-deprivation therapy for prostate cancer.
Holzbeierlein JM; Castle EP; Thrasher JB
Clin Prostate Cancer; 2003 Dec; 2(3):147-52. PubMed ID: 15040857
[TBL] [Abstract][Full Text] [Related]
10. Managing hot flashes in men being treated for prostate cancer.
Baum NH; Torti DC
Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
[TBL] [Abstract][Full Text] [Related]
11. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
13. Management of complications of androgen deprivation therapy in the older man.
Mohile SG; Mustian K; Bylow K; Hall W; Dale W
Crit Rev Oncol Hematol; 2009 Jun; 70(3):235-55. PubMed ID: 18952456
[TBL] [Abstract][Full Text] [Related]
14. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
[TBL] [Abstract][Full Text] [Related]
15. Hot flashes in prostate cancer: state of the science.
Engstrom CA
Am J Mens Health; 2008 Jun; 2(2):122-32. PubMed ID: 19477776
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation.
Vandecasteele K; Ost P; Oosterlinck W; Fonteyne V; Neve WD; Meerleer GD
Phytother Res; 2012 Feb; 26(2):208-13. PubMed ID: 21630361
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
Ulloa EW; Salup R; Patterson SG; Jacobsen PB
Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
Gonzalez BD; Small BJ; Cases MG; Williams NL; Fishman MN; Jacobsen PB; Jim HSL
Cancer; 2018 Feb; 124(3):499-506. PubMed ID: 29072790
[TBL] [Abstract][Full Text] [Related]
19. Managing complications of androgen deprivation therapy for prostate cancer.
Holzbeierlein JM
Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
